Alzheimer's disease: synaptic dysfunction and Aβ

被引:380
|
作者
Shankar, Ganesh M. [1 ,2 ]
Walsh, Dominic M. [3 ]
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Lab Neurodegenerat Res, Dublin 4, Ireland
来源
MOLECULAR NEURODEGENERATION | 2009年 / 4卷
关键词
LONG-TERM POTENTIATION; MILD COGNITIVE IMPAIRMENT; SOLUBLE AMYLOID OLIGOMERS; PROTEIN TRANSGENIC MICE; TG2576 MOUSE MODEL; RAT DENTATE GYRUS; HIPPOCAMPAL-NEURONS; PLAQUE-FORMATION; MOLECULAR-BASIS; IN-VIVO;
D O I
10.1186/1750-1326-4-48
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong correlation between the extent of synapse loss and the severity of dementia. Accordingly, it has been proposed that synapse loss underlies the memory impairment evident in the early phase of AD and that since plasticity is important for neuronal viability, persistent disruption of plasticity may account for the frank cell loss typical of later phases of the disease. Extensive multi-disciplinary research has implicated the amyloid beta-protein (A beta) in the aetiology of AD and here we review the evidence that non-fibrillar soluble forms of A beta are mediators of synaptic compromise. We also discuss the possible mechanisms of A beta synaptotoxicity and potential targets for therapeutic intervention.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Compensating for synaptic loss in Alzheimer's disease
    Abuhassan, Kamal
    Coyle, Damien
    Belatreche, Ammar
    Maguire, Liam
    JOURNAL OF COMPUTATIONAL NEUROSCIENCE, 2014, 36 (01) : 19 - 37
  • [42] Olfactory dysfunction in Alzheimer's disease
    Zou, Yong-ming
    Lu, Da
    Liu, Li-ping
    Zhang, Hui-hong
    Zhou, Yu-ying
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 869 - 875
  • [43] Noradrenergic dysfunction in Alzheimer's disease
    Gannon, Mary
    Che, Pulin
    Chen, Yunjia
    Jiao, Kai
    Roberson, Erik D.
    Wang, Qin
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [44] Malignant synaptic growth and Alzheimer's disease
    Newman, Ehren L.
    Shay, Christopher F.
    Hasselmo, Michael E.
    FUTURE NEUROLOGY, 2012, 7 (05) : 557 - 571
  • [45] Melatonin in Synaptic Impairments of Alzheimer's Disease
    Shi, Yan
    Fang, Ying-Yan
    Wei, Yu-Ping
    Jiang, Qian
    Zeng, Peng
    Tang, Na
    Lu, Youming
    Tian, Qing
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (03) : 911 - 926
  • [46] Effects of synaptic plasticity regulated by 17β-estradiol on learning and memory in rats with Alzheimer's disease
    Shang, Xiu-Li
    Zhao, Jiu-Han
    Cao, Yun-Peng
    Xue, Yi-Xue
    NEUROSCIENCE BULLETIN, 2010, 26 (02) : 133 - 139
  • [47] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02) : 320 - 330
  • [48] The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease
    Gu, Xun-Hu
    Xu, Li Jun
    Liu, Zhi-Qiang
    Wei, Bo
    Yang, Yuan-Jian
    Xu, Guo-Gang
    Yin, Xiao-Ping
    Wang, Wei
    BEHAVIOURAL BRAIN RESEARCH, 2016, 311 : 309 - 321
  • [49] Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
    Thorsell, Annika
    Bjerke, Maria
    Gobom, Johan
    Brunhage, Eva
    Vanmechelen, Eugeen
    Andreasen, Niels
    Hansson, Oskar
    Minthon, Lennart
    Zetterberg, Henrik
    Blennow, Kaj
    BRAIN RESEARCH, 2010, 1362 : 13 - 22
  • [50] Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer's Disease
    Juergensen, Sofia
    Ferreira, Sergio T.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2010, 40 (1-2) : 221 - 229